Catecholamine-induced cardiomyopathy is an uncommon complication of pheochromocytoma. Pheochromocytoma is a rare tumor that predominantly occurs in adults, making catecholamine-induced cardiomyopathy secondary to pheochromocytoma in children an exceedingly rare presentation. Treatment typically consists of medical management followed by surgical resection.
View Article and Find Full Text PDFPurpose: This study aims to comprehensively delineate the phenotypic spectrum of ACTL6B-related disorders, previously associated with both autosomal recessive and autosomal dominant neurodevelopmental disorders. Molecularly, the role of the nucleolar protein ACTL6B in contributing to the disease has remained unclear.
Methods: We identified 105 affected individuals, including 39 previously reported cases, and systematically analysed detailed clinical and genetic data for all individuals.
Background: Umbilical arterial catheterization is a common procedure performed on critically ill neonates, especially those with extreme prematurity. Various complications have been described following umbilical artery catheter (UAC) placement including thrombosis, embolism, vasospasm, vascular perforation, hemorrhage, and infection. However, treatment of these complications is challenging due to the small size of this very fragile subset of patients.
View Article and Find Full Text PDFIntroduction: Multiple device closure (MDC) strategy has been used in treating of complex Atrial septal defects (ASDs) in adults. The safety profile of MDC compared to conventional single device closure (SDC) is unknown in this population. This report represents the first review examining the outcomes of single versus multiple device ASD closure in adults with ostium secundum defects.
View Article and Find Full Text PDFCatheter Cardiovasc Interv
February 2019
AVP ll and ADO ll AS devices are effective and safe for percutaneous PDA closure. Residual shunt and serious complications are uncommon Mild LPA stenosis and device embolization are the most frequent complications reported.
View Article and Find Full Text PDFCatheter Cardiovasc Interv
June 2018
Neonatal percutaneous carotid access is a safe technique that compares favorably to neonatal surgical carotid access. Mid-term ultrasound and angiographic follow after percutaneous carotid access shows 100% vessel patency rate with no severe stenoses or aneurysms detected. Mild stenosis (<12%) is frequent at follow up (35%), the clinical significance of which is unknown.
View Article and Find Full Text PDFCatheter Cardiovasc Interv
January 2018
Catheter Cardiovasc Interv
August 2017
Catheter access to the "native" atria is limited after extra-cardiac Fontan palliation of univentricular cardiac defects Catheter access to the atria is necessary to percutaneously treat acquired abnormalities after extra-cardiac Fontan palliation Direct trans-thoracic atrial access and extra-cardiac conduit puncture is technically straightforward and allows for novel catheter interventions.
View Article and Find Full Text PDFCatheter Cardiovasc Interv
June 2016
Catheter Cardiovasc Interv
November 2015
Continuous echo guidance may add to the safety of neonatal aortic balloon valvuloplasty Trans-carotid access is an alternative route to aortic balloon valvuloplasty in neonates Proof of preferred procedure (surgical or catheter based), procedure setting, and access site remains elusive as the disease is infrequent and single center experience remains small.
View Article and Find Full Text PDFA 64-year-old male with Budd-Chiari syndrome (BCS) due to inferior vena cava (IVC) occlusion after liver transplant presented with massive ascites and lower extremity edema. He was found to have chronic total occlusion of the supra-hepatic IVC with thrombosis in the infra-hepatic IVC, hepatic, renal, and iliac veins. Attempts to recanalize the occlusion by multiple operators failed.
View Article and Find Full Text PDFCatheter Cardiovasc Interv
September 2013
A 52-year-old male patient, with a medical history of surgically repaired double outlet right ventricle presented with severe aortic stenosis (AS) and hepatitis C with cirrhosis, presented with New York Heart Association Class IV heart failure. During evaluation for a liver transplant, he was deemed a poor surgical candidate due to his aortic valve disease and cirrhosis with model for end-stage liver disease score of 14. Transthoracic echocardiogram showed severe AS with a mean gradient of 62 mm Hg and calculated aortic valve area of 0.
View Article and Find Full Text PDFCatheter Cardiovasc Interv
November 2012
Catheter Cardiovasc Interv
November 2011
Catheter Cardiovasc Interv
July 2011
Catheter Cardiovasc Interv
January 2011
Catheter Cardiovasc Interv
November 2010